Viral Hepatitis

 

Viral hepatitis is a global public health problem that affects millions of people worldwide each year, causing disability and death. Appropriate measures such as vaccination, safe injections, a safe diet, and a safe blood supply can reduce the rate of transmission of viral hepatitis. Many of these measures not only reduce the transmission of viral hepatitis but also affect the prevention of various other communicable diseases. Additionally, current treatments for hepatitis B and C provide healthcare providers with powerful tools to combat the disease. New advanced antiretroviral drugs such as TDF, 3TC, and FTC are effective in treating HIV and HBV infections. Co-infection therapy for hepatitis B and hepatitis C is also being developed, and the future looks brighter than ever. d The patient can take fewer medications to treat these two conditions for her. Viral hepatitis can also be prevented by timely vaccination and good hygiene.

·         Screening Tests

·         Antiretrovirals

·         Safe Injection Practices

·         Blood Safety Strategies

·         Assessment and Management of Chronically Infected Persons

·         Personal and Community Health

·         Antivirals Such as Lamivudine and Adefovir

·         Pegylated Interferon Injections

  • Antiretrovirals
  • Blood Safety Strategies

Viral Hepatitis Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in